{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:06:42Z","timestamp":1789520802025,"version":"build-2803163510"},"reference-count":242,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["RSG-21-032-01-CSM"],"award-info":[{"award-number":["RSG-21-032-01-CSM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbcan.2026.189684","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:27:40Z","timestamp":1786663660000},"page":"189684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug resistance in breast cancer brain metastasis: mechanisms and therapeutic strategies"],"prefix":"10.1016","volume":"1881","author":[{"given":"Paromita","family":"Sarker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189684_bb0005","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-015-0665-1","article-title":"Breast cancer brain metastases: biology and new clinical perspectives","volume":"18","author":"Witzel","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0010","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","article-title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","volume":"23","author":"Kuksis","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41416-020-01175-y","article-title":"Treatment strategies for breast cancer brain metastases","volume":"124","author":"Bailleux","year":"2021","journal-title":"Brit. J. Cancer"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189684_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16132466","article-title":"New frontiers in the treatment of patients with HER2+ cancer and brain metastases: is radiotherapy always useful?","volume":"16","author":"Scandurra","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0025","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/neuonc\/noac118","article-title":"Brain metastases: a Society for Neuro-Oncology (SNO) consensus review on current management and future directions","volume":"24","author":"Aizer","year":"2022","journal-title":"Neuro-Oncology"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189684_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.trecan.2019.06.003","article-title":"Improving CNS delivery to Brain metastases by blood-tumor barrier disruption","volume":"5","author":"Sprowls","year":"2019","journal-title":"Trends Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189684_bb0035","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/RLI.0b013e318226c427","article-title":"In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach","volume":"46","author":"Percy","year":"2011","journal-title":"Investig. Radiol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ccell.2015.01.001","article-title":"Emerging strategies for treating brain metastases from breast cancer","volume":"27","author":"Kodack","year":"2015","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nm.4120","article-title":"Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases","volume":"22","author":"Ni","year":"2016","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189684_bb0050","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1158\/1078-0432.CCR-17-3351","article-title":"Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the Brain?","volume":"24","author":"Kabraji","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189684_bb0055","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/1078-0432.CCR-10-1564","article-title":"Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer","volume":"16","author":"Lockman","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bjc.2016.34","article-title":"Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes","volume":"114","author":"Thomson","year":"2016","journal-title":"Brit. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0065","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1016\/S1470-2045(20)30556-8","article-title":"The genomic landscape of breast cancer brain metastases: a systematic review","volume":"22","author":"Morgan","year":"2021","journal-title":"Lancet Oncol."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189684_bb0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2322688121","article-title":"Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies","volume":"121","author":"Goyette","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7604","key":"10.1016\/j.bbcan.2026.189684_bb0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer","volume":"533","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189684_bb0080","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"391","key":"10.1016\/j.bbcan.2026.189684_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4682","article-title":"The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation","volume":"9","author":"Kodack","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju145","article-title":"DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer","volume":"106","author":"Woditschka","year":"2014","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189684_bb0095","article-title":"Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1\/ERBB2 therapy","volume":"74","author":"Cruickshanks","year":"2014","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0100","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1158\/1078-0432.CCR-13-2588","article-title":"Profound prevention of experimental Brain metastases of breast cancer by Temozolomide in an MGMT-dependent manner","volume":"20","author":"Palmieri","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"35","key":"10.1016\/j.bbcan.2026.189684_bb0105","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1038\/onc.2012.417","article-title":"Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis","volume":"32","author":"Louie","year":"2013","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.bbcan.2026.189684_bb0110","doi-asserted-by":"crossref","first-page":"23396","DOI":"10.1021\/acsami.1c02822","article-title":"Multifunctional liposomes enable active targeting and Twinfilin 1 silencing to reverse paclitaxel resistance in brain metastatic breast cancer","volume":"13","author":"Du","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cmet.2021.12.001","article-title":"Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness","volume":"34","author":"Parida","year":"2022","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189684_bb0120","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1002\/ijc.32742","article-title":"LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer","volume":"146","author":"Blazquez","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189684_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112022","article-title":"Enhanced 5-methylcytosine methylation of PSD4 facilitates vasculogenic mimicry in breast cancer brain metastases through ferroptotic resistance","volume":"135","author":"Li","year":"2025","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0130","first-page":"893","article-title":"Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases","volume":"4","author":"Parida","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189684_bb0135","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-25-4894","article-title":"Targetable S100-RAGE signaling mediates intrinsic trastuzumab deruxtecan resistance in metastatic breast cancer","author":"Dong","year":"2026","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0140","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1471-4159.2007.04808.x","article-title":"Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec\u00ae) across the mouse blood\u2013brain barrier","volume":"102","author":"Bihorel","year":"2007","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0145","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11095-011-0601-8","article-title":"Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer","volume":"29","author":"Taskar","year":"2012","journal-title":"Pharm. Res.-Dordr."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0150","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/neuonc\/noab041","article-title":"Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer","volume":"23","author":"Wang","year":"2021","journal-title":"Neuro-Oncology"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0155","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.apsb.2024.03.024","article-title":"Suppressing Wnt signaling of the blood-tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases","volume":"14","author":"Tong","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbcan.2026.189684_bb0160","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2024.03.047","article-title":"Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy","volume":"369","author":"Mu","year":"2024","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-024-01509-5","article-title":"Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition","volume":"26","author":"Yuzhalin","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0170","first-page":"1086","article-title":"Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis","volume":"2","author":"Klemm","year":"2021","journal-title":"Nat. Can."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01455-4","article-title":"Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer","volume":"11","author":"Yokoi","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115427","article-title":"The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis","volume":"44","author":"Wischnewski","year":"2025","journal-title":"Cell Rep."},{"issue":"545","key":"10.1016\/j.bbcan.2026.189684_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz5387","article-title":"Blocking immunosuppressive neutrophils deters pY696-EZH2-driven brain metastases","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neo.2014.11.007","article-title":"Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer","volume":"17","author":"Zhang","year":"2015","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb0195","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/bit.70144","article-title":"Astrocytes protect Brain metastatic breast cancer cells from chemotherapy through CX43 dependent STAT1 signaling in co-culture spheroids","volume":"123","author":"Yakati","year":"2026","journal-title":"Biotechnol. Bioeng."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s44385-025-00043-9","article-title":"An in vitro hydrogel-based model to study dormancy associated drug resistance in metastatic breast cancer spheroids","volume":"2","author":"Sarker","year":"2025","journal-title":"npj Biomed. Innov."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0205","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1021\/acsbiomaterials.5c00644","article-title":"Glucocorticoid receptor signaling mediates resistance to therapy in matrix rigidity-induced dormant brain metastatic breast cancer spheroids","volume":"11","author":"Luna","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bbcan.2026.189684_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150142","article-title":"Laminin I mediates resistance to lapatinib in HER2-positive brain metastatic breast cancer cells","volume":"720","author":"Gurung","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189684_bb0215","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1039\/D4BM00342J","article-title":"Matrix stiffness influences response to chemo and targeted therapy in brain metastatic breast cancer cells","volume":"12","author":"Yakati","year":"2024","journal-title":"Biomater. Sci-Uk."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0220","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1593\/neo.11112","article-title":"Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy","volume":"13","author":"Kim","year":"2011","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189684_bb0225","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/neuonc\/nou128","article-title":"Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells","volume":"16","author":"Kim","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb0230","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/neuonc\/now037","article-title":"Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel","volume":"18","author":"Lee","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189684_bb0235","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of Brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb0240","first-page":"245","article-title":"EGFR and HER2 signaling in breast cancer brain metastasis","volume":"8","author":"Sirkisoon","year":"2016","journal-title":"Front. Biosci. (Elite Ed.)"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0245","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10555-020-09881-y","article-title":"Molecular and cellular mechanisms underlying brain metastasis of breast cancer","volume":"39","author":"Hosonaga","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"7576","key":"10.1016\/j.bbcan.2026.189684_bb0250","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature15376","article-title":"Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth","volume":"527","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189684_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.628690","article-title":"Activation of PI3K\/AKT\/mTOR pathway causes drug resistance in breast cancer","volume":"12","author":"Dong","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189684_bb0260","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.04.35","article-title":"Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies","volume":"6","author":"Brosnan","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010152","article-title":"Breast cancer brain metastases: clonal evolution in clinical context","volume":"18","author":"Saunus","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189684_bb0270","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/s41388-025-03315-1","article-title":"The epigenetic landscape of brain metastasis","volume":"44","author":"Powell","year":"2025","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb0275","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-0004.2011.01809.x","article-title":"Epigenetic modifications in cancer","volume":"81","author":"Kanwal","year":"2012","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbcan.2026.189684_bb0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","article-title":"Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential","volume":"6","author":"Gan","year":"2018","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41420-025-02368-1","article-title":"Capsanthin inhibits migration and reduces N-linked glycosylation of PD-L1 via the EZH2-PD-L1 axis in triple-negative breast cancer brain metastasis","volume":"11","author":"Chien","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189684_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216706","article-title":"EZH2-mediated development of therapeutic resistance in cancer","volume":"586","author":"Kaur","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189684_bb0295","doi-asserted-by":"crossref","first-page":"155992","DOI":"10.1016\/j.prp.2025.155992","article-title":"EZH2 regulatory roles in cancer immunity and immunotherapy","volume":"270","author":"Mortezaee","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189684_bb0300","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1158\/0008-5472.CAN-18-3264","article-title":"EN1 is a transcriptional dependency in triple-negative breast cancer associated with brain metastasis","volume":"79","author":"Peluffo","year":"2019","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb0305","article-title":"Transcriptome analysis reveals the potential role of neural factor EN1 for long-terms survival in estrogen receptor-independent breast cancer","volume":"33","author":"Ren","year":"2025","journal-title":"Mol. Ther. Oncol"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-026-02568-y","article-title":"piR-1170 drives brain metastasis and immune evasion via WTAP-mediated m6A methylation reprogramming in triple-negative breast cancer","volume":"25","author":"Luo","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189684_bb0315","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ncrna.2025.08.009","article-title":"NSUN2-mediated m5C hypermethylation of hsa_circ_0004516 promotes breast cancer brain metastasis by activating AKT signaling","volume":"14","author":"Li","year":"2025","journal-title":"Noncoding RNA Res."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0320","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djae091","article-title":"RET overexpression leads to increased brain metastatic competency in luminal breast cancer","volume":"116","author":"Jagust","year":"2024","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0325","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","article-title":"ESR1 mutations\u2014a mechanism for acquired endocrine resistance in breast cancer","volume":"12","author":"Jeselsohn","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0330","first-page":"197","article-title":"Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution","volume":"42","author":"Francescangeli","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2026.189684_bb0335","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","article-title":"Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance","volume":"43","author":"Bhat","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0340","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-023-01383-x","article-title":"Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies","volume":"8","author":"Shi","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11912-026-01753-y","article-title":"Breast cancer brain metastases: current understanding and future directions","volume":"28","author":"Alabdulrahman","year":"2026","journal-title":"Curr. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0350","article-title":"Regulating the dormancy of cancer stem cells: a novel approach to preventing cancer relapse","volume":"17","author":"Wang","year":"2026","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0355","first-page":"211","article-title":"Intrinsic and extrinsic regulators of cancer dormancy and awakening","volume":"6","author":"Zhang","year":"2026","journal-title":"J. Natl. Cancer Cent."},{"issue":"40","key":"10.1016\/j.bbcan.2026.189684_bb0360","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1038\/s41388-025-03529-3","article-title":"Decoding the adaptive survival mechanisms of breast cancer dormancy","volume":"44","author":"Barnieh","year":"2025","journal-title":"Oncogene"},{"issue":"7604","key":"10.1016\/j.bbcan.2026.189684_bb0365","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer","volume":"533","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0370","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0375","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1158\/1541-7786.MCR-10-0457","article-title":"Notch1 inhibition alters the CD44\/\/CD24 population and reduces the formation of brain Metastases from breast cancer","volume":"9","author":"McGowan","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189684_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112442","article-title":"BR-BCSC signature: the cancer stem cell profile enriched in brain metastases that predicts a worse prognosis in lymph node-positive breast cancer","volume":"9","author":"Dion\u00edsio","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb0385","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5496","article-title":"Advances in understanding the role and mechanisms of tumor stem cells in HER2-positive breast cancer treatment resistance (review)","volume":"62","author":"Xu","year":"2023","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101569","article-title":"Breast cancer stem cells as drivers of tumor chemoresistance, dormancy and relapse: new challenges and therapeutic opportunities","volume":"11","author":"De Angelis","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189684_bb0395","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ctrv.2018.07.004","article-title":"Cancer stem cell in breast cancer therapeutic resistance","volume":"69","author":"Bai","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061897","article-title":"DNA repair and therapeutic strategies in Cancer stem cells","volume":"15","author":"Gillespie","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020381","article-title":"Autophagy regulation on cancer stem cell maintenance, metastasis, and therapy resistance","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189684_bb0410","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semcancer.2018.11.006","article-title":"Therapy resistance mediated by cancer stem cells","volume":"53","author":"Steinbichler","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189684_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091903","article-title":"Roles of Long noncoding RNAs in recurrence and metastasis of radiotherapy-resistant cancer stem cells","volume":"18","author":"Chi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2018.11.015","article-title":"Cancer stem cells: road to therapeutic resistance and strategies to overcome resistance","volume":"1866","author":"Makena","year":"2020","journal-title":"BBA-Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0425","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-00627-5","article-title":"Drug resistance and cancer stem cells","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0430","article-title":"Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Tar."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189684_bb0435","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1158\/0008-5472.CAN-17-2994","article-title":"Targeting Brain-adaptive Cancer stem cells prohibits Brain metastatic colonization of triple-negative breast cancer","volume":"78","author":"Ren","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189684_bb0440","article-title":"Molecular phenotypic plasticity informs possible adaptive change of triple-negative breast cancer cells in vivo","author":"Iftehimul","year":"2025","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189684_bb0445","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41416-021-01424-8","article-title":"Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies","volume":"125","author":"Wang","year":"2021","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189684_bb0450","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.semcancer.2021.02.004","article-title":"Disseminated cancer cells in breast cancer: mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities","volume":"78","author":"Ramamoorthi","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0455","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.canlet.2013.06.020","article-title":"Overview: cellular plasticity, cancer stem cells and metastasis","volume":"341","author":"ElShamy","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189684_bb0460","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcancer.2021.04.021","article-title":"Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis","volume":"78","author":"Basu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0465","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic latency and immune evasion through autocrine inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189684_bb0470","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1039\/D0BM00969E","article-title":"Matrix stiffness and cluster size collectively regulate dormancy versus proliferation in brain metastatic breast cancer cell clusters","volume":"8","author":"Kondapaneni","year":"2020","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0475","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4143\/crt.2023.468","article-title":"Cellular dormancy in cancer: mechanisms and potential targeting strategies","volume":"55","author":"Min","year":"2023","journal-title":"Cancer Res. Treat."},{"issue":"43","key":"10.1016\/j.bbcan.2026.189684_bb0480","doi-asserted-by":"crossref","first-page":"E9066","DOI":"10.1073\/pnas.1704862114","article-title":"Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer","volume":"114","author":"Sansone","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189684_bb0485","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1158\/1078-0432.CCR-13-0838","article-title":"Metastasis dormancy in estrogen receptor-positive breast cancer","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189684_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.00072","article-title":"Cellular plasticity in breast cancer progression and therapy","volume":"7","author":"Kong","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0495","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.stem.2018.11.011","article-title":"Phenotypic plasticity: driver of cancer initiation, progression, and therapy resistance","volume":"24","author":"Gupta","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb0500","first-page":"414","article-title":"Fatty acid synthesis is required for breast cancer brain metastasis","volume":"2","author":"Ferraro","year":"2021","journal-title":"Nat. Can."},{"issue":"37","key":"10.1016\/j.bbcan.2026.189684_bb0505","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/s41388-019-0893-4","article-title":"FABP7 is a key metabolic regulator in HER2+breast cancer brain metastasis","volume":"38","author":"Cordero","year":"2019","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020089","article-title":"Metabolic reprogramming in breast cancer and its therapeutic implications","volume":"8","author":"Gandhi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189684_bb0515","article-title":"Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity","volume":"7","author":"Cioce","year":"2024","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.bbcan.2026.189684_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.791927","article-title":"Metabolic reprogramming underlying brain metastasis of breast cancer","volume":"8","author":"Liu","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189684_bb0525","article-title":"Metabolic reprogramming by an epigenetic mechanism in endocrine therapy resistance of breast cancer","volume":"74","author":"Zou","year":"2014","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189684_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133351","article-title":"Metabolic reprogramming: a friend or foe to cancer therapy?","volume":"13","author":"McCann","year":"2021","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189684_bb0535","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41388-024-03054-9","article-title":"A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance","volume":"43","author":"Das","year":"2024","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.bbcan.2026.189684_bb0540","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1158\/0008-5472.CAN-25-3006","article-title":"ACSS2 suppresses ferroptosis to drive breast cancer brain metastasis","volume":"86","author":"Young","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189684_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217907","article-title":"NF-kappaB-mediated cytokine secretion and glutamate metabolic reprogramming converge in breast cancer brain tropism","volume":"630","author":"Di Russo","year":"2025","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13070778","article-title":"The cancer antioxidant regulation system in therapeutic resistance","volume":"13","author":"Gu","year":"2024","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0555","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.7150\/ijbs.65555","article-title":"High expression of G6PD increases doxorubicin resistance in triple negative breast cancer cells by maintaining GSH level","volume":"18","author":"Luo","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189684_bb0560","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1111\/jcmm.14241","article-title":"Nrf2 promotes breast cancer cell migration via up-regulation of G6PD\/HIF-1\u03b1\/Notch1 axis","volume":"23","author":"Zhang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189684_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.550469","article-title":"PKM2-c-Myc-survivin cascade regulates the cell proliferation, migration, and tamoxifen resistance in breast cancer","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189684_bb0570","article-title":"The metabolic mechanisms of breast cancer metastasis","volume":"10","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189684_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.608412","article-title":"Microenvironmental determinants of breast cancer metastasis: focus on the crucial interplay between estrogen and insulin\/insulin-like growth factor signaling","volume":"8","author":"Vella","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/biom13071084","article-title":"Leptin: a heavyweight player in obesity-related cancers","volume":"13","author":"Caruso","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2026.189684_bb0585","series-title":"Anatomy, Head and Neck: Blood Brain Barrier","author":"Dotiwala","year":"2025"},{"key":"10.1016\/j.bbcan.2026.189684_bb0590","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","article-title":"Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders","volume":"1628","author":"Qosa","year":"2015","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189684_bb0595","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4155\/tde.15.48","article-title":"Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer","volume":"6","author":"Papademetriou","year":"2015","journal-title":"Ther. Deliv."},{"issue":"42","key":"10.1016\/j.bbcan.2026.189684_bb0600","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp9530","article-title":"BCRP drives intrinsic chemoresistance in chemotherapy-naive breast cancer brain metastasis","volume":"9","author":"Uceda-Castro","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189684_bb0605","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5741-y","article-title":"Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review","volume":"19","author":"van Bussel","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2026.189684_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood-Brain barrier and delivery of protein and gene therapeutics to Brain","volume":"11","author":"Pardridge","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189684_bb0615","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1158\/1078-0432.CCR-16-1327","article-title":"Impact of blood-brain barrier integrity on tumor growth and therapy response in brain metastases","volume":"22","author":"Osswald","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0620","doi-asserted-by":"crossref","first-page":"210","DOI":"10.21037\/qims-2025-1998","article-title":"Correlation between contrast-enhanced T2 fluid-attenuated inversion recovery enhancement and dynamic contrast-enhanced magnetic resonance imaging permeability in brain metastases","volume":"16","author":"Zhang","year":"2026","journal-title":"Quant. Imaging Med. Surg."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189684_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112599","article-title":"Non-invasive drug delivery across the blood-Brain barrier: a prospective analysis","volume":"15","author":"Niazi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189684_bb0630","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1200\/JCO.18.01511","article-title":"TBCRC 022: a phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases","volume":"37","author":"Freedman","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189684_bb0635","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2015.63.0343","article-title":"Translational breast cancer research consortium (TBCRC) 022: a phase II trial of Neratinib for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases","volume":"34","author":"Freedman","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189684_bb0640","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/cncr.11436","article-title":"Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma","volume":"97","author":"Bendell","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189684_bb0645","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.7150\/ijbs.58916","article-title":"Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a\/BRD4 axis","volume":"17","author":"Fu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.10.004","article-title":"YTHDF3 induces the translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis","volume":"38","author":"Chang","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0655","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70038","article-title":"Breast cancer-derived extracellular vesicles modulate the cytoplasmic and cytoskeletal dynamics of blood-brain barrier endothelial cells","volume":"14","author":"Busatto","year":"2025","journal-title":"J. Extracell. Vesicles"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0660","first-page":"690","article-title":"Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier","volume":"22","author":"Wang","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189684_bb0665","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.immuni.2022.04.012","article-title":"Immunological defense of CNS barriers against infections","volume":"55","author":"Ampie","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0670","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1530\/VB-19-0033","article-title":"Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation","volume":"2","author":"Marchetti","year":"2020","journal-title":"Vasc Biol"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb0675","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1158\/2326-6066.CIR-19-0786","article-title":"Immune escape during breast tumor progression","volume":"8","author":"Del Alcazar","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"61","key":"10.1016\/j.bbcan.2026.189684_bb0680","doi-asserted-by":"crossref","first-page":"103671","DOI":"10.18632\/oncotarget.22110","article-title":"Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer","volume":"8","author":"Ogiya","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189684_bb0685","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-016-0702-8","article-title":"Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1\/PD-L axis","volume":"18","author":"Duchnowska","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0690","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41590-024-01960-4","article-title":"The complexity of immune evasion mechanisms throughout the metastatic cascade","volume":"25","author":"Haynes","year":"2024","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0695","doi-asserted-by":"crossref","first-page":"169","DOI":"10.14336\/AD.2023.0514","article-title":"The role of microglia in Brain metastases: mechanisms and strategies","volume":"15","author":"Feng","year":"2024","journal-title":"Aging Dis."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0700","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/cbin.12226","article-title":"Tumor-associated macrophages: a sentinel of innate immune system in tumor microenvironment gone haywire","volume":"48","author":"Malik","year":"2024","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbcan.2026.189684_bb0705","article-title":"Signal pathways involved in the interaction between tumor-associated macrophages\/TAMs and glioblastoma cells","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189684_bb0710","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189684_bb0715","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2741\/4573","article-title":"The roles of microglia\/macrophages in tumor progression of brain cancer and metastatic disease","volume":"22","author":"Wu","year":"2017","journal-title":"Front. Biosci-Landmrk."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0720","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.4049\/jimmunol.1402603","article-title":"Intratumoral delivery of IL-21 overcomes anti-Her2\/Neu resistance through shifting tumor-associated macrophages from M2 to M1 phenotype","volume":"194","author":"Xu","year":"2015","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0725","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/oncolo\/oyac064","article-title":"Immune checkpoint inhibitors in the treatment of breast Cancer Brain metastases","volume":"27","author":"Schlam","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.bbcan.2026.189684_bb0730","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz095.003","article-title":"Relationship between tumor infiltrating lymphocytes (TILs) and response to pembrolizumab (pembro) plus chemotherapy (CT) as neoadjuvant treatment (NAT) for triple-negative breast cancer (TNBC): phase Ib KEYNOTE-173 trial","volume":"30","author":"Loi","year":"2019","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0735","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-014421","article-title":"Spatial immune atlas of breast cancer brain metastasis reveals CD163(+) macrophage reprogramming associated with immune escape","volume":"14","author":"Zhu","year":"2026","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189684_bb0740","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4441-3","article-title":"Mechanisms of immune evasion in breast cancer","volume":"18","author":"Bates","year":"2018","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb0745","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10585-017-9839-9","article-title":"Astrocyte-induced Reelin expression drives proliferation of Her2 Breast cancer metastases","volume":"34","author":"Jandial","year":"2017","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0750","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0755","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189684_bb0760","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1426033","article-title":"Pericytes: jack-of-all-trades in cancer-related inflammation","volume":"15","author":"Moro","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"7775","key":"10.1016\/j.bbcan.2026.189684_bb0765","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","article-title":"Synaptic proximity enables NMDAR signalling to promote brain metastasis","volume":"573","author":"Zeng","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189684_bb0770","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41388-022-02584-4","article-title":"Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions","volume":"42","author":"Jayachandran","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189684_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217132","article-title":"The intersection of the nervous system and breast cancer","volume":"598","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb0780","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/cam4.105","article-title":"Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?","volume":"2","author":"Donnem","year":"2013","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0785","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10456-019-09691-z","article-title":"Vessel co-option in glioblastoma: emerging insights and opportunities","volume":"23","author":"Seano","year":"2020","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189684_bb0790","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular co-option in brain metastasis","volume":"156","author":"Valiente","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb0795","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-024-01808-0","article-title":"Immunoengineering can overcome the glycocalyx Armour of cancer cells","volume":"23","author":"Park","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.bbcan.2026.189684_bb0800","doi-asserted-by":"crossref","DOI":"10.1038\/srep43006","article-title":"Cellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factors","volume":"7","author":"Peiris","year":"2017","journal-title":"Sci. Rep."},{"issue":"7509","key":"10.1016\/j.bbcan.2026.189684_bb0805","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nature13535","article-title":"The cancer glycocalyx mechanically primes integrin-mediated growth and survival","volume":"511","author":"Paszek","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189684_bb0810","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nrc2761","article-title":"Mucins in cancer: function, prognosis and therapy","volume":"9","author":"Kufe","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0815","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-023-04944-z","article-title":"Critical functions of extracellular matrix in brain metastasis seeding","volume":"80","author":"Yuzhalin","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2026.189684_bb0820","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01358","article-title":"Proteoglycans as therapeutic targets in brain cancer","volume":"10","author":"Yan","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189684_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102521","article-title":"Molecular aspects of brain metastases in breast cancer","volume":"114","author":"Tomasik","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2026.189684_bb0830","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1191980","article-title":"Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain","volume":"13","author":"Sunderland","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0835","first-page":"25","article-title":"Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain","volume":"3","author":"Dai","year":"2022","journal-title":"Nat. Can."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189684_bb0840","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s11010-024-05175-x","article-title":"Mechanisms of breast cancer metastasis: the role of extracellular matrix","volume":"480","author":"Chen","year":"2025","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189684_bb0845","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.onc.1208238","article-title":"A novel CYR61-triggered \u2018CYR61-\u03b1v\u03b23 integrin loop\u2019 regulates breast cancer cell survival and chemosensitivity through activation of ERK1\/ERK2 MAPK signaling pathway","volume":"24","author":"Menendez","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189684_bb0850","article-title":"Integrin signaling in cancer cell survival and chemoresistance","volume":"2012","author":"Aoudjit","year":"2012","journal-title":"Chemother Res Pract"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189684_bb0855","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.apsb.2021.01.004","article-title":"Integrins as attractive targets for cancer therapeutics","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0860","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16832-2","article-title":"Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowth","volume":"11","author":"Howe","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0865","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","article-title":"Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0870","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1158\/0008-5472.CAN-19-2961","article-title":"Proteomic profiling of the ECM of xenograft breast Cancer metastases in different organs reveals distinct metastatic niches","volume":"80","author":"Hebert","year":"2020","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189684_bb0875","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The interplay between extracellular matrix remodeling and cancer therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov."},{"issue":"19","key":"10.1016\/j.bbcan.2026.189684_bb0880","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1158\/0008-5472.CAN-19-4021","article-title":"Soft microenvironments induce chemoresistance by increasing autophagy downstream of integrin-linked kinase","volume":"80","author":"Anlas","year":"2020","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189684_bb0885","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051250","article-title":"The role of extracellular matrix proteins in breast Cancer","volume":"11","author":"Lepucki","year":"2022","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0890","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189684_bb0895","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.actbio.2020.02.039","article-title":"An invitro hyaluronic acid hydrogel based platform to model dormancy in brain metastatic breast cancer cells","volume":"107","author":"Narkhede","year":"2020","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0900","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1038\/s41467-024-50558-9","article-title":"Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial","volume":"15","author":"Balinda","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb0905","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/neuonc\/noac180","article-title":"Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis","volume":"25","author":"Oberkampf","year":"2023","journal-title":"Neuro-Oncology"},{"issue":"20","key":"10.1016\/j.bbcan.2026.189684_bb0910","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1158\/1078-0432.CCR-20-1764","article-title":"A phase II study of Abemaciclib in patients with Brain metastases secondary to hormone receptor-positive breast cancer","volume":"26","author":"Tolaney","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0915","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJMoa1914609","article-title":"Tucatinib, Trastuzumab, and Capecitabine for HER2-positive metastatic breast cancer","volume":"382","author":"Murthy","year":"2020","journal-title":"New Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189684_bb0920","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/1078-0432.CCR-19-3258","article-title":"ANG1005, a brain-penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal Carcinomatosis and recurrent brain metastases","volume":"26","author":"Kumthekar","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189684_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103614","article-title":"Efficacy and safety of ARX788 for individuals with HER2-positive breast cancer and brain metastases (ACE-Breast-06): a single-arm, phase 2 trial in China","volume":"90","author":"Li","year":"2025","journal-title":"Eclinicalmedicine"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189684_bb0930","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/neuonc\/noae123","article-title":"Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases","volume":"26","author":"Bartsch","year":"2024","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189684_bb0935","first-page":"JCO2502021","article-title":"Phase II clinical study of Adebrelimab and bevacizumab combined with cisplatin\/carboplatin in patients with triple-negative breast cancer with Brain metastases (ABC study)","volume":"44","author":"Li","year":"2026","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0940","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1470-2045(12)70432-1","article-title":"Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study","volume":"14","author":"Bachelot","year":"2013","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189684_bb0945","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.annonc.2020.06.020","article-title":"Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial(\u2606)","volume":"31","author":"Montemurro","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189684_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102837","article-title":"Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial","volume":"76","author":"Yan","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0955","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41523-024-00656-0","article-title":"Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasion","volume":"10","author":"Serhan","year":"2024","journal-title":"Npj Breast Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb0960","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.ajpath.2013.02.043","article-title":"Pazopanib inhibits the activation of PDGFR\u03b2-expressing astrocytes in the Brain metastatic microenvironment of breast cancer cells","volume":"182","author":"Gril","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb0965","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3625","article-title":"A deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity","volume":"16","author":"McMullin","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189684_bb0970","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1104594","article-title":"Blood-tumor barrier opening by MRI-guided transcranial focused ultrasound in a preclinical breast cancer brain metastasis model improves efficacy of combinatorial chemotherapy","volume":"13","author":"Arsiwala","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb0975","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10549-022-06783-1","article-title":"EGFR as a potent CAR T target in triple negative breast cancer brain metastases","volume":"197","author":"Subham","year":"2023","journal-title":"Breast Cancer Res. Tr."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189684_bb0980","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1158\/0008-5472.CAN-18-1102","article-title":"Loss of XIST in breast cancer activates MSN-c-met and reprograms microglia via Exosomal miRNA to promote Brain metastasis","volume":"78","author":"Xing","year":"2018","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb0985","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.034850","article-title":"Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis","volume":"11","author":"Kim","year":"2018","journal-title":"Dis. Model. Mech."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189684_bb0990","doi-asserted-by":"crossref","DOI":"10.1007\/s10585-025-10366-x","article-title":"A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models","volume":"42","author":"Zhang","year":"2025","journal-title":"Clin. Exp. Metastasis"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189684_bb0995","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/neuonc\/nox052","article-title":"Combined kinase inhibitors of MEK1\/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer","volume":"19","author":"Van Swearingen","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1000","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-06200-x","article-title":"Brain endothelial cells promote breast cancer cell extravasation to the brain via EGFR-DOCK4-RAC1 signalling","volume":"7","author":"Galloni","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2026.189684_bb1005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.850656","article-title":"Inhibition of anti-inflammatory macrophage phenotype reduces tumour growth in mouse models of brain metastasis","volume":"12","author":"Economopoulos","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1010","article-title":"Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance","volume":"3","author":"Kotecha","year":"2021","journal-title":"Neurooncol. Adv."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11864-024-01286-1","article-title":"Central nervous system metastases in breast cancer","volume":"26","author":"Grinda","year":"2025","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.bbcan.2026.189684_bb1020","article-title":"Breast cancer brain metastasis: from molecular insights to therapeutic innovation","volume":"17","author":"Han","year":"2026","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bbcan.2026.189684_bb1025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082122","article-title":"Effects of Cancer stem cells in triple-negative breast cancer and brain metastasis: challenges and solutions","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb1030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.37349\/etat.2022.00081","article-title":"Endocrine resistant breast cancer: brain metastasis","volume":"3","author":"Willman","year":"2022","journal-title":"Explor. Target Antitumor. Ther."},{"issue":"34","key":"10.1016\/j.bbcan.2026.189684_bb1035","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2420793122","article-title":"Macrophage TBK1 signaling drives the development and outgrowth of breast cancer brain metastasis","volume":"122","author":"Khan","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb1040","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030667","article-title":"Preclinical models of brain metastases in breast cancer","volume":"10","author":"Knier","year":"2022","journal-title":"Biomedicines"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189684_bb1045","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1200\/JCO.20.00775","article-title":"Intracranial efficacy and survival with Tucatinib plus Trastuzumab and Capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial","volume":"38","author":"Lin","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.bbcan.2026.189684_bb1050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244164","article-title":"Current evidence in the systemic treatment of brain metastases from breast cancer and future perspectives on new drugs, combinations and administration routes: a narrative review","volume":"16","author":"Garrone","year":"2024","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.bbcan.2026.189684_bb1055","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1158\/1078-0432.CCR-17-0754","article-title":"MONARCH 1, a phase II study of Abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR(+)\/HER2(\u2212) metastatic breast cancer","volume":"23","author":"Dickler","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189684_bb1060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111661","article-title":"Should all patients with HR-positive HER2-negative metastatic breast cancer receive CDK 4\/6 inhibitor as first-line based therapy? A network Meta-analysis of data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT trials","volume":"11","author":"Rossi","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189684_bb1065","doi-asserted-by":"crossref","first-page":"873","DOI":"10.18632\/oncotarget.27904","article-title":"Is there a role for CDK 4\/6 inhibitors in breast cancer brain metastases?","volume":"12","author":"Schlam","year":"2021","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1070","article-title":"Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitors","volume":"8","author":"Giannoudis","year":"2024","journal-title":"npj Precis. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb1075","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/neuonc\/noad038","article-title":"Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults","volume":"25","author":"Weller","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189684_bb1080","series-title":"Cancer Chemotherapy","author":"Amjad","year":"2026"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189684_bb1085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2165\/00023210-200721070-00003","article-title":"CNS complications of breast cancer: current and emerging treatment options","volume":"21","author":"Kaal","year":"2007","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb1090","doi-asserted-by":"crossref","first-page":"986","DOI":"10.20892\/j.issn.2095-3941.2020.0128","article-title":"HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and antitumor efficacy of paclitaxel in an orthotopic brain tumor model","volume":"17","author":"Zeng","year":"2020","journal-title":"Cancer Biol. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.bbcan.2026.189684_bb1095","first-page":"v133","article-title":"Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases","volume":"3","author":"Blethen","year":"2021","journal-title":"Neurooncol. Adv."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189684_bb1100","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1038\/s41591-024-03261-7","article-title":"Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b\/4 trial","volume":"30","author":"Harbeck","year":"2024","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189684_bb1105","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-026-07932-6","article-title":"A phase II study of atezolizumab in combination with stereotactic radiation for patients with triple-negative breast cancer and brain metastasis","volume":"216","author":"Giordano","year":"2026","journal-title":"Breast Cancer Res. Treat."},{"issue":"7668","key":"10.1016\/j.bbcan.2026.189684_bb1110","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1158\/1078-0432.CCR-17-2041","article-title":"Regional delivery of chimeric antigen receptor-engineered T cells effectively targets HER2(+) breast cancer metastasis to the brain","volume":"24","author":"Priceman","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189684_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118669","article-title":"Neurologic complications of immune checkpoint inhibitors: a comprehensive review","volume":"192","author":"Lashkajani","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"14","key":"10.1016\/j.bbcan.2026.189684_bb1125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16142585","article-title":"Immune-related adverse events induced by immune checkpoint inhibitors and CAR-T cell therapy: a comprehensive imaging-based review","volume":"16","author":"Pozzessere","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189684_bb1130","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-017-1370-x","article-title":"Comprehensive molecular biomarker identification in breast cancer brain metastases","volume":"15","author":"Schulten","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189684_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102786","article-title":"Long road towards effective HER3 targeting in breast cancer","volume":"129","author":"Papa","year":"2024","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/neuonc\/noae163","article-title":"Analysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survival","volume":"27","author":"Pereslete","year":"2025","journal-title":"Neuro-Oncology"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189684_bb1145","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s12282-026-01841-8","article-title":"Expression of HER2, HER3, and TROP2 in primary tumors and brain metastases of breast cancer","volume":"33","author":"Kusuhara","year":"2026","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1150","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb1155","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000253","article-title":"Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases","volume":"2","author":"Siravegna","year":"2017","journal-title":"ESMO Open"},{"key":"10.1016\/j.bbcan.2026.189684_bb1160","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189684_bb1165","doi-asserted-by":"crossref","first-page":"19199","DOI":"10.1002\/jcp.28656","article-title":"A new insight on serum microRNA expression as novel biomarkers in breast cancer patients","volume":"234","author":"Bahmanpour","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189684_bb1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109506","article-title":"Tumor-derived extracellular vesicles as a biomarker for breast cancer diagnosis and metastasis monitoring","volume":"27","author":"Xu","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bbcan.2026.189684_bb1175","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221112698","article-title":"Prognostic\/predictive markers in systemic therapy resistance and metastasis in breast cancer","volume":"14","author":"Hobbs","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"55","key":"10.1016\/j.bbcan.2026.189684_bb1180","doi-asserted-by":"crossref","first-page":"94969","DOI":"10.18632\/oncotarget.21662","article-title":"18F-Fluoromisonidazole in tumor hypoxia imaging","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7150\/thno.16676","article-title":"Preclinical applications of 3\u2019-Deoxy-3\u2032-[(18)F]Fluorothymidine in oncology - a systematic review","volume":"7","author":"Schelhaas","year":"2017","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189684_bb1190","doi-asserted-by":"crossref","first-page":"11275","DOI":"10.1021\/acsami.3c17863","article-title":"Fabrication of a Coculture organoid model in the biomimetic matrix of alginate to investigate breast cancer progression in a TAMs-leading immune microenvironment","volume":"16","author":"Xu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpt.2023.10.005","article-title":"Experimental models for cancer brain metastasis","volume":"2","author":"Liu","year":"2024","journal-title":"Cancer Pathog. Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189684_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2026.03.016","article-title":"Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes","volume":"44","author":"Jassowicz","year":"2026","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189684_bb1205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4143\/crt.2025.033","article-title":"Spatial transcriptomic landscape of Brain metastases from triple-negative breast cancer: comparison of primary tumor and Brain metastases using spatial analysis","volume":"58","author":"Yoo","year":"2026","journal-title":"Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189684_bb1210","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1038\/s41591-024-03215-z","article-title":"A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features","volume":"30","author":"Klughammer","year":"2024","journal-title":"Nat. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:19:34Z","timestamp":1789517974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":242,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0304419X26001563"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189684","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug resistance in breast cancer brain metastasis: mechanisms and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189684"}}